1-6 of 6
Michelle Y. Doral
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study

L. Elizabeth Budde, Laurie H. Sehn, Matthew J. Matasar, Stephen J. Schuster, Sarit Assouline, Pratyush Giri, John Kuruvilla, Miguel Canales, Sascha Dietrich, Keith Fay, Matthew Ku, Loretta Nastoupil, Michael C. Wei, Shen Yin, Michelle Y. Doral, Chi-Chung Li, Huang Huang, Raluca Negricea, Elicia Penuel, Carol O'Hear, Nancy L. Bartlett
Journal: Blood
Blood (2021) 138 (Supplement 1): 127.
https://doi.org/10.1182/blood-2021-145872
Published: 2021
Journal Articles

Mosunetuzumab Shows Promising Efficacy in Patients with Multiply Relapsed Follicular Lymphoma: Updated Clinical Experience from a Phase I Dose-Escalation Trial

Sarit E Assouline, MD MSc, Won Seog Kim, MD PhD, Laurie H. Sehn, MDMPH, Stephen J. Schuster, MD, Chan Yoon Cheah, MBBS, Loretta J. Nastoupil, MD, Mazyar Shadman, Sung-Soo Yoon, MD PhD, Matthew J Matasar, MD, Catherine Diefenbach, MD, Gareth P. Gregory, Nancy L. Bartlett, MD, Michael C. Wei, Michelle Y. Doral, Shen Yin, Raluca Negricea, Chi-Chung Li, Elicia M. Penuel, Huang Huang, L. Elizabeth Budde
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-135839
Published: 2020
Journal Articles

A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

Clinical Trials & Observations
Guy Young, Ri Liesner, Tiffany Chang, Robert Sidonio, Jr, Johannes Oldenburg, Victor Jiménez-Yuste, Johnny Mahlangu, Rebecca Kruse-Jarres, Michael Wang, Marianne Uguen, Michelle Y. Doral, Lilyan Y. Wright, Christophe Schmitt, Gallia G. Levy, Midori Shima, Maria Elisa Mancuso
Journal: Blood
Blood (2019) 134 (24): 2127–2138.
https://doi.org/10.1182/blood.2019001869
Published: 2019
Includes: Supplemental data
Journal Articles

Identification of CRLF2 Genomic Lesions in Patients with Pediatric B-Precursor Acute Lymphoblastic Leukemia (BCP ALL) by Flow Cytometry or Quantitative RT-PCR: A Children's Oncology Group (COG) Stud.

Richard C. Harvey, PhD, Brent L. Wood, MD, PhD, I-Ming Chen, DVM, MS, Michelle Y Doral, BS, Kristie Yu, Meenakshi Devidas, PhD, Julie M. Gastier-Foster, PhD, Eric C. Larsen, MD, Kelly W. Maloney, MD, Elizabeth Raetz, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Cheryl L Willman, MD, Mignon L. Loh, MD
Journal: Blood
Blood (2012) 120 (21): 2529.
https://doi.org/10.1182/blood.V120.21.2529.2529
Published: 2012
Journal Articles

Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2 -rearranged B-precursor acute lymphoblastic leukemia

Sarah K. Tasian, Michelle Y. Doral, Michael J. Borowitz, Brent L. Wood, I-Ming Chen, Richard C. Harvey, Julie M. Gastier-Foster, Cheryl L. Willman, Stephen P. Hunger, Charles G. Mullighan, Mignon L. Loh
Journal: Blood
Blood (2012) 120 (4): 833–842.
https://doi.org/10.1182/blood-2011-12-389932
Published: 2012
Includes: Supplemental data
Journal Articles

Thymic Stromal Lymphopoietin Stimulation of Pediatric Acute Lymphoblastic Leukemias with CRLF2 Alterations Induces JAK/STAT and PI3K Phosphosignaling

Sarah K Tasian, MD, Michelle Y Doral, BS, Brent L Wood, MD, PhD, Michael J Borowitz, MD, PhD, J. Racquel Collins-Underwood, PhD, Richard C Harvey, PhD, Kathleen M Sakamoto, MD, PhD, Cheryl L. Willman, MD, Stephen P Hunger, MD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Mignon L Loh, MD
Journal: Blood
Blood (2010) 116 (21): 410.
https://doi.org/10.1182/blood.V116.21.410.410
Published: 2010